Dr. Douglas G. Ebersole, MD

Dr. Ebersole practices at Watson Clinic in Lakeland, Florida.

Dr. Ebersole's NPI, 1972575736, was assigned on February 6, 2006. Dr. Ebersole graduated from University of Miami, Miller School of Medicine in 1986. Dr. Ebersole holds Florida license ME51795.

Dr. Ebersole's primary practice is Watson Clinic, at 1430 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 680-7700.

Dr. Ebersole's primary practice is Watson Clinic in Lakeland, Florida. Dr. Ebersole is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Watson Clinic. Dmand AI also links Dr. Ebersole to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ebersole practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Ebersole's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Ebersole is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ebersole is licensed in Florida.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Ebersole treats.

CMS data shows 143 Medicare services from Dr. Ebersole across 4 procedure codes in 2024, for 103 Medicare patients. Medicare paid $28,688 for them.

CMS counts 103 Medicare patients who saw Dr. Ebersole in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have atrial fibrillation, and 75% have high blood pressure. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ebersole's median patient age at 79, with 47% women.

In 2024, Dr. Ebersole wrote 68 Medicare Part D claims for 42 patients. 87% of them were for generic drugs. CMS names the drug for 39 of them, across 1 drug with 11 or more claims each, at $473 in total drug cost. In 2023, CMS named 66 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Ebersole for performance year 2024, reported through an alternative payment model (APM). Dr. Ebersole accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Ebersole, published from 2007 to 2019. The most frequent topics are Myocardial Infarction, Coronary Angiography and Angioplasty, Balloon, Coronary. Dr. Ebersole has published most often in Cathet Cardiovasc Diagn. Dr. Ebersole's most frequent co-authors are Tony S. Das, MD, John Dean Baker, MD and Hooman Madyoon, MD.

Dmand AI links Dr. Ebersole to 1 clinical trial. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 458 general payments to Dr. Ebersole from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $237,994.

Dmand AI lists 3 awards for Dr. Ebersole, most recently CMS Stage 1 EHR in 2012.

Dr. Ebersole graduated from University of Miami, Miller School of Medicine in 1986. Dr. Ebersole is a member of ACC.

Dr. Ebersole is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.